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Lymphocytes that can’t let go
 
On page 1987, Semmrich and colleagues
T cells that express a constitutively activated 
form of the integrin LFA-1 (bottom) have 
restricted mobility compared to those 
expressing wild-type LFA-1 (top).
 
show that immune cells expressing a
perpetually activated form of the inte-
grin LFA-1 get traction at the front of
the cell, but get stuck from behind.
Their lagging ends prevent them from
crawling through the endothelium and
initiating a normal immune response.
Integrins, such as LFA-1, are ad-
hesive molecules that switch between
active and inactive conformations and
control migration of circulating immune
cells to sites of infection and inflam-
mation. LFA-1 is also required for the
formation of stable interactions between
T cells and antigen presenting cells
(APCs). Previous studies had shown that
both tumor-specific T cell responses and
neutrophil migration are compromised in
the absence of this integrin.
The importance of LFA-1 deacti-
vation, however, has been less clear.
In vitro studies have shown that locking
LFA-1 in its activated conformation
impairs both neutrophil chemotaxis
and T cell activation. Semmrich et al.
now confirm these findings in vivo,
and show that lymphocytes from
 
Indecisive interleukin-4?
 
A study on page 1899 may explain the seemingly fickle ways 
of the cytokine interleukin (IL)-4. Yao and colleagues show 
how this quintessential T helper (Th) 2 cytokine can sometimes 
promote the opposite Th1 response.
The prototypic Th2 cytokine IL-4 inhibits IL-10 production by DCs, 
thereby increasing the production of the Th1-promoting cytokine IL-12.
 
mice  expressing a constitutively ac-
tive LFA-1 moved more slowly than
wild-type cells and failed to migrate
across endothelial cell monolayers.
Video microscopy revealed that these
defective movements were due to an
inability of the cells to release their
trailing edges.
CD4
 
 
 
 T cell proliferation and anti-
body production were also impaired in
these mice. The development of antigen-
specific CD8
 
 
 
 cytotoxic T cells, by
contrast, was not altered by the mutated
LFA-1, but the ability of these cells to
lyse  target cells was decreased. The
authors suggest that defects in T cell
activation and function may reflect
the need for serial engagement of
T cell receptors with peptide–MHC
complexes on APCs, a process that
may be compromised by the inability
to inactivate LFA-1 and thus to terminate
cell–cell contacts.
Mice expressing the mutant LFA-1
closely resembled mice lacking the
protein completely, suggesting that,
for immune cells, letting go is just as
important as grabbing on.
 
IL-4 is known as the key cytokine for polarizing naive T 
cells toward a Th2 phenotype, which is important for antibody 
production and protection against parasitic infections. Under 
some conditions, however, IL-4 has been shown to instead 
induce a Th1 response. Indeed, a recent study showed that mice 
treated with IL-4 during initial infection with 
 
Leishmania major
 
 
had increased Th1 responses and were protected. If given later, 
IL-4 increased Th2 responses and exacerbated disease.
Yao et al. now suggest that the regulation of another 
cytokine—IL-10—may explain these perplexing observations. They 
show that dendritic cells (DCs) stimulated in the presence of IL-4 
made less IL-10 than those stimulated without IL-4. As a result, 
the IL-4–treated DCs produced more of the Th1-polarizing 
cytokine IL-12—known to be inhibited by IL-10—and polarized 
naive T cells toward a Th1 phenotype more effectively. IL-10 was 
critical for the increased Th1 response, as IL-4 did not increase IL-12 
production or T cell polarization by IL-10–deficient DCs.
IL-4 had the opposite effect on B cells, provoking increased 
IL-10 production. The authors suggest that the differential 
effect of IL-4 at different times during infection may reflect a 
switch from DCs to B cells as the predominant cell type that is 
presenting antigen.
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